IS THERE TREATMENT EFFECT OF VINPOCETINE ON AUTONOMIC DYSFUNCTION IN RATS WITH ALZHEIMER
Journal Title: Asian Journal of Pharamceutical and Clinical Research - Year 2017, Vol 10, Issue 2
Abstract
Alzheimer's disease (AD) shows less autonomic dysfunction. There was lack of response or prolongation of its latency in skin sympathetic response. Vinpocetine is a classic inhibitor of PDE1 activity. Vinpocetine treatment has been shown to enhance performance on cognitive tests in humans. The efficacy of the use of vinpocetine in clinical trials has been controversial. A comparison of multiple studies evaluating vinpocetine use in Alzheimer's disease AD was recently conducted. Objective: Our first aim was to assess dysautonomia in rat with Alzheimer's disease AD electrophysiologically, using sympathetic skin response (SSR) test. The second aim in this study, evaluate of the effect of vinpocetine treatment on Alzheimer autonomic dysfunction and attention deficiency.Method: Rats were divided into four groups: Sham group (Group C, i.p. saline), Alzheimer group (Group A), Vinpocetine group (Group V, 5mg/kg, every other day, i.p.), Alzheimer+ Vinpocetine group (Group AV). Alzheimer's disease was induced in old male rats by AlCl3 (40 mg/kg i.p.) and D-Galactose (90 mg/kg) daily for 6 weeks. Then Skin Conductance Level (SCL), which is a sympathetic skin response parameter, was measured as tonic (no-stimuli period, 2 min) and phasic SSR (simultaneously with 15 auditory stimuli, 10 min). Tonic SSR is useful to investigate general states of arousal and alertness, while phasic SSR is useful to study multifaceted attentional processes (related to novelty, intensity). Results: SCL was difference among groups (tonic: F=21.47, p≤0.000; phasic: F=9.86, p≤0.000). Skin conductance level (SCL) was statistically lower in Group A than Group C (p≤0.005) and Group V (p≤0.000). SCL of Group V was statistically higher then Group C (p≤0.04), Group A (p≤0.000) and Group AV (p≤0.000). SCL of Group AV was lower than Group C’s (p≤0.01). Conclusion: There were no statistically difference between Group A and Group AV. We concluded that autonomic disturbances accompanied Alzheimer's disease and vinpocetine treatment couldn’t ameliorate this disturbance. Keywords: Autonomic dysfunction, Dysautonomia, Inhibitor, Skin conductance level, Sympathetic skin response Â
Authors and Affiliations
Azizuddin Khan, Nazan Dolu, Seda Gündüz, Ali Yucel Kara, Hale Acer, Selda Tasa
STABILITY-INDICATING HIGH-PERFORMANCE THIN-LAYER CHROMATOGRAPHY METHOD FOR SIMULTANEOUS ESTIMATION OF FORMOTEROL FUMARATE DIHYDRATE AND FLUTICASONE PROPIONATE IN BULK DRUG AND PHARMACEUTICAL DOSAGE FORM
Objective: The objective of the present work was to develop validated stability-indicating high-performance thin-layer chromatographic method for simultaneous estimation of formoterol fumarate dihydrate (FFD) and flutica...
ETHNOBOTANICAL AND ETHNOVETERINARY IMPORTANCE OF PLANTS OF SCRUB AREAS OF DACHIGAM NATIONAL PARK, JAMMU AND KASHMIR, INDIA
Objective: The rich plant diversity of mountains has been used by the indigenous people for thousands of years as health-care remedies. A study on the important plant communities of scrub ecosystems of Dachigam National...
STOOL FORM SCALE AS AN INDICATOR OF KLUTUK BANANA (MUSA BALBISIANA COLLA) FRUIT EXTRACTS INHIBITION EFFECT AGAINST SHIGELLA DYSENTERIAE ATCC 13313 IN VIVO
  Objective: Stools consistency is a common symptom indicating in dysenteriae. The aim of this study was to investigate the inhibitory effect of the klutuk banana fruit extract that determine different degrees of stool...
SPECTROSCOPIC CHARACTERIZATION OF PHYTOCONSTITUENTS ISOLATED FROM A RARE MANGROVE AEGIALITIS ROTUNDIFOLIA ROXB., LEAVES AND EVALUATION OF ANTIMICROBIAL ACTIVITY OF THE CRUDE EXTRACT
Objective: The aim of the study is to isolate and characterize the phytochemicals from the leaves of a rare and unexplored mangrove Aegialitis rotundifolia and evaluate the antimicrobial properties of the crude extract....
DESIGNING A VACCINE FOR CANCER: A LOOK INTO DENDRITIC CELL CANCER VACCINE
The fundamental premise behind clinical approaches for dendritic cell-mediated immunization in cancer is that the limiting defect in natural antitumor immunity is at the level of antigen presentation. In contrast to vacc...